Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential

@article{Rucker2015PsychedelicDS,
  title={Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential},
  author={J. Rucker},
  journal={BMJ : British Medical Journal},
  year={2015},
  volume={350}
}
  • J. Rucker
  • Published 2015
  • Medicine
  • BMJ : British Medical Journal
Trials of physiologically safe and non-addictive drugs such as LSD are almost impossible, writes James J H Rucker, calling on the authorities to downgrade their unnecessarily restrictive class A, schedule 1 classification 
Changes Need To Be Made To Make Research More Feasible on Scheduled Drugs for Recreational Purposes as Well
  • J. Brenner
  • Medicine
  • The American journal of bioethics : AJOB
  • 2016
TLDR
It is suggested that marijuana has medicinal purposes, and has been shown to be effective for managing debilitating pain, nausea, and vomiting associated with chemotherapy, decreasin and other diseases. Expand
Psychedelics: Old drugs, new trips
TLDR
This special edition of the Journal of Psychopharmacology continues a reflection of psychopharmacological’s vogue to breathe new life into old drugs, with a characterisation of the relevance of the 5-HT2A receptor to the psychedelic state, and a study of the neural and subjective effects of a short acting psychedelic. Expand
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
TLDR
Rigorous scientific evidence coupled with industrial interests (LSD and psilocybin), together with respect for traditional uses (ayahuasca) and international conventions, seems to be the best way for these drugs to be integrated into health systems in the next years. Expand
Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?
TLDR
Three articles rise the fundamental question of mechanism behind therapeutic effects of hallucinogenic and entactogenic substances, which patients might benefit from these treatments and which might not, how therapeutic effects can be promoted and risks further minimized. Expand
A Public-Health-Based Vision for the Management and Regulation of Psychedelics
TLDR
A public-health-based model for the regulation of psychedelics is described, which includes governance, supervision, set and setting controls, youth access, supply control, demand limitation, and evaluation. Expand
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
TLDR
The evidence to date is strongest for the use of LSD in the treatment of alcoholism, and new studies that conform to modern standards are necessary in order to strengthen knowledge on its use and open new doors in the future. Expand
The link between use of psychedelic drugs and mental health problems
TLDR
It is argued that the authors’ conclusions in their latest paper are not substantiated by their results and will propose supplemental analyses to validate or potentially revise their conclusions. Expand
Back to the future: Research renewed on the clinical utility of psychedelic drugs
TLDR
The use of psilocybin in the treatment of depression and anxiety in cancer patients and a substantial therapeutic effect of two drug administrations in a crossover design on the target symptoms of anxiety and depression in a heterogeneous group of cancer patients with comorbid psychopathology are described. Expand
Psychedelics in the treatment of unipolar mood disorders: a systematic review
TLDR
The evidence overall strongly suggests that psychedelics should be re-examined in modern clinical trials for their use in unipolar mood disorders and other non-psychotic mental health conditions. Expand
Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research
International research is increasingly demonstrating that psychedelic‐assisted psychotherapy can enhance psychotherapeutic outcomes and be effective for some treatment‐refractory mental illnesses;Expand
...
1
2
...

References

SHOWING 1-10 OF 26 REFERENCES
Effects of Schedule I drug laws on neuroscience research and treatment innovation
TLDR
An important and unfortunate outcome of the controls placed on these and other psychoactive drugs is that they make research into their mechanisms of action and potential therapeutic uses difficult and in many cases almost impossible. Expand
ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE
  • R. Strassman
  • Psychology, Medicine
  • The Journal of nervous and mental disease
  • 1984
TLDR
The basic pharmacology of the major synthetic psychedelic compounds (primarily lysergic acid diethylamide [LSD]-25) is described and reference is made to their potentially beneficial psychological effects. Expand
Psychedelic Drugs Reconsidered
Convention on psychotropic substances, 1971. The role and responsibilities of the World Health Organization.
  • I. Khan
  • Political Science, Medicine
  • Progress in neuro-psychopharmacology
  • 1979
TLDR
The Convention on Psychotropic Substances, 1971, is aimed at controlling psychotropic substances and was formulated in Vienna in 1971 and lays a great responsibility on the World Health Organization to recommend to the United Nations Commission on Narcotic Drugs notifications initiated by the World health Organization. Expand
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
TLDR
In a controlled clinical environment, psilocybin was safely used in subjects with OCD and was associated with acute reductions in core OCD symptoms in several subjects. Expand
Psychedelics and Mental Health: A Population Study
TLDR
It was found that in several cases psychedelic use was associated with lower rate of mental health problems, and use of psychedelics was not found to be an independent risk factor formental health problems. Expand
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
TLDR
The Pharmacological Basis of Therapeutics, by Prof. Louis Goodman and Prof. Alfred Gilman, New York: The Macmillan Company, 1941, p. Expand
Response of cluster headache to psilocybin and LSD
TLDR
The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition to find out whether these patients had aborted attacks or reported remission period extension. Expand
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
TLDR
A single dose of LSD, in the context of various alcoholism treatment programs, is associated with a decrease in alcohol misuse, and there was evidence for a beneficial effect of LSD on alcohol misuse. Expand
Psychedelics not linked to mental health problems or suicidal behavior: A population study
TLDR
Overall, it is difficult to see how prohibition of psychedelics can be justified as a public health measure, after adjusting for sociodemographics, other drug use and childhood depression. Expand
...
1
2
3
...